AGNELLO VINCENT has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1993. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are KINCH MICHAEL S, ST VINCENTS HOSP SYDNEY and TARGETED MOLECULAR DIAGNOSTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Agnello Vincent | 18 |
Publication | Filing date | Title |
---|---|---|
CN102859360A | Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients | |
CA2425513A1 | Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell | |
CA2138536A1 | Chemiluminescent Assay for dsDNA Antibodies |